Close Menu

Mutually Beneficial

Jeff Bluestone tells Xconomy San Francisco that, as a result of recent advances in genomics, partnerships between academia and industry are both "logical and appropriate." Industry's impressive investment in data generation "has actually left a hole" in terms of functional interpretation, says Bluestone, an executive vice chancellor and provost at the University of California, San Francisco.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.